JPS4864097A - - Google Patents

Info

Publication number
JPS4864097A
JPS4864097A JP47123877A JP12387772A JPS4864097A JP S4864097 A JPS4864097 A JP S4864097A JP 47123877 A JP47123877 A JP 47123877A JP 12387772 A JP12387772 A JP 12387772A JP S4864097 A JPS4864097 A JP S4864097A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP47123877A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US245870A external-priority patent/US3925385A/en
Application filed filed Critical
Publication of JPS4864097A publication Critical patent/JPS4864097A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP47123877A 1971-12-09 1972-12-09 Pending JPS4864097A (instruction)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20653871A 1971-12-09 1971-12-09
US245870A US3925385A (en) 1972-04-20 1972-04-20 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines
US27346572A 1972-07-20 1972-07-20
US29984072A 1972-10-24 1972-10-24

Publications (1)

Publication Number Publication Date
JPS4864097A true JPS4864097A (instruction) 1973-09-05

Family

ID=27498614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP47123877A Pending JPS4864097A (instruction) 1971-12-09 1972-12-09

Country Status (15)

Country Link
JP (1) JPS4864097A (instruction)
BE (1) BE792533A (instruction)
BG (1) BG22401A3 (instruction)
CH (1) CH603652A5 (instruction)
DD (1) DD104530A5 (instruction)
DE (1) DE2257547A1 (instruction)
GB (1) GB1412017A (instruction)
HU (1) HU168530B (instruction)
IE (1) IE37189B1 (instruction)
IL (1) IL40895A (instruction)
LU (1) LU66597A1 (instruction)
NL (1) NL7216539A (instruction)
NO (1) NO137012C (instruction)
RO (1) RO62762A (instruction)
SE (1) SE398751B (instruction)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018504A1 (fr) * 1991-04-22 1992-10-29 Otsuka Pharmaceutical Factory, Inc. DERIVE DE PYRAZOLO[1,5-a]PYRIMIDINE ET AGENT ANTI-INFLAMMATOIRECONTENANT CE DERIVE
WO1995035298A1 (fr) * 1994-06-21 1995-12-28 Otsuka Pharmaceutical Factory, Inc. DERIVE DE PYRAZOLO[1,5-a]PYRIMIDINE
JP2007522220A (ja) * 2004-02-11 2007-08-09 シェーリング コーポレイション サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン誘導体

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
AU557300B2 (en) * 1982-03-16 1986-12-18 Farmitalia Carlo Erba S.P.A. Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
DE3533050A1 (de) * 1985-09-17 1987-03-26 Basf Ag 7-amino-azolo(1,5-a)pyrimidine, verfahren zu ihrer herstellung und diese enthaltende fungizide, bzw. deren verwendung als fungizide
CA1330079C (en) * 1988-10-13 1994-06-07 Michihiko Tsujitani Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same
DE4333705C2 (de) * 1993-10-02 2003-10-30 Guenter Ege Arylmethylsubstituierte Pyrazolo-azine, insbesondere 3-Arylmethylpyrazolo[1,5-a]pyrimidine und Verfahren zur Herstellung von 8-Arylmethyl-pyrazolo[5,1-c][1,2,4]triazinen
CN1169149A (zh) * 1995-09-28 1997-12-31 株式会社大制药工场 止痛组合物
FR2771631B1 (fr) * 1997-12-03 2001-02-02 Oreal Compositions de teinture des fibres keratiniques contenant des 3-amino pyrazolo-[1,5-a]-pyrimidines, procede de teinture, nouvelles 3-amino pyrazolo- [1,5-a]-pyrimidines et leur procede de preparation
ATE469903T1 (de) * 2002-09-04 2010-06-15 Schering Corp Zur behandlung von krebserkrankungen geeignete pyrazolopyrimidine
US7161003B1 (en) 2002-09-04 2007-01-09 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
TWI252851B (en) * 2003-07-24 2006-04-11 Ferrer Int 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto
KR101793807B1 (ko) 2013-04-25 2017-11-03 베이진 엘티디 단백질 키나제 억제제로서의 융합된 헤테로시클릭 화합물
BR112016005408B1 (pt) 2013-09-13 2023-03-21 Beigene Switzerland Gmbh Anticorpos anti-pd1, f(ab) ou f(ab)2 e uso referido anticorpo para tratamento de cancer ou infecção viral
KR102130600B1 (ko) 2014-07-03 2020-07-08 베이진 엘티디 Pd-l1 항체와 이를 이용한 치료 및 진단
US10864203B2 (en) 2016-07-05 2020-12-15 Beigene, Ltd. Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
KR20250052473A (ko) 2016-08-16 2025-04-18 베이진 스위찰랜드 게엠베하 (s)-7-(1-아크릴로일피페리딘-4-일)-2-(4-페녹시페닐)-4,5,6,7-테트라-하이드로피라졸로[1,5-a] 피리미딘-3-카르복스아미드의 제조 및 그 용도
HUE065528T2 (hu) 2016-08-19 2024-06-28 Beigene Switzerland Gmbh Zanubrutinib kombinációja anti-CD20 vagy anti-PD-1 antitesttel rák kezelésében történõ alkalmazásra
EP3573989A4 (en) 2017-01-25 2020-11-18 Beigene, Ltd. CRYSTALLINE FORMS OF (S) -7- (1- (BUT-2-YNOYL) PIPERIDIN-4-YL) -2- (4-PHENOXYPHENYL) -4, 5, 6, 7-TETRAHY DROPYRAZOLO [1, 5-A ] PYRIMIDINE-3-CARBOXAMIDE, PREPARATION AND ASSOCIATED USES
KR102757960B1 (ko) 2017-06-26 2025-01-22 베이진 엘티디 간세포암(hepatocellular carcinoma: HCC)에 대한 면역 치료
WO2019034009A1 (en) 2017-08-12 2019-02-21 Beigene, Ltd. BTK INHIBITOR WITH ENHANCED DOUBLE SELECTIVITY
US11786529B2 (en) 2017-11-29 2023-10-17 Beigene Switzerland Gmbh Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors
WO2020249001A1 (zh) 2019-06-10 2020-12-17 百济神州瑞士有限责任公司 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
US11786531B1 (en) 2022-06-08 2023-10-17 Beigene Switzerland Gmbh Methods of treating B-cell proliferative disorder

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018504A1 (fr) * 1991-04-22 1992-10-29 Otsuka Pharmaceutical Factory, Inc. DERIVE DE PYRAZOLO[1,5-a]PYRIMIDINE ET AGENT ANTI-INFLAMMATOIRECONTENANT CE DERIVE
WO1995035298A1 (fr) * 1994-06-21 1995-12-28 Otsuka Pharmaceutical Factory, Inc. DERIVE DE PYRAZOLO[1,5-a]PYRIMIDINE
JP2007522220A (ja) * 2004-02-11 2007-08-09 シェーリング コーポレイション サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン誘導体
JP2010215675A (ja) * 2004-02-11 2010-09-30 Schering Corp サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン誘導体
JP4845743B2 (ja) * 2004-02-11 2011-12-28 シェーリング コーポレイション サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン誘導体

Also Published As

Publication number Publication date
DE2257547A1 (de) 1973-06-14
SE398751B (sv) 1978-01-16
HU168530B (instruction) 1976-05-28
BG22401A3 (bg) 1977-02-20
RO62762A (fr) 1978-05-15
BE792533A (fr) 1973-06-08
IL40895A0 (en) 1973-01-30
LU66597A1 (instruction) 1973-03-15
NO137012C (no) 1977-12-14
DD104530A5 (instruction) 1974-03-12
IE37189L (en) 1973-06-09
NL7216539A (instruction) 1973-06-13
GB1412017A (en) 1975-10-29
IE37189B1 (en) 1977-05-25
NO137012B (no) 1977-09-05
CH603652A5 (instruction) 1978-08-31
IL40895A (en) 1976-12-31

Similar Documents

Publication Publication Date Title
HU168530B (instruction)
AU2658571A (instruction)
AU2691671A (instruction)
AU2894671A (instruction)
AU3005371A (instruction)
AU2564071A (instruction)
AU2941471A (instruction)
AU2952271A (instruction)
AU2684071A (instruction)
AU2726271A (instruction)
AU2742671A (instruction)
AU2577671A (instruction)
AU2740271A (instruction)
AU2588771A (instruction)
AU2885171A (instruction)
AU2880771A (instruction)
AU2875571A (instruction)
AU2854371A (instruction)
AU2837671A (instruction)
AU2836771A (instruction)
AU2755871A (instruction)
AU2907471A (instruction)
AU2940971A (instruction)
AU2669471A (instruction)
AU2724971A (instruction)